IBDEI2WZ ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,46479,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46479,1,3,0)
;;=3^Family Hx Blindness/Visual Loss
;;^UTILITY(U,$J,358.3,46479,1,4,0)
;;=4^Z82.1
;;^UTILITY(U,$J,358.3,46479,2)
;;=^5063365
;;^UTILITY(U,$J,358.3,46480,0)
;;=Z83.518^^176^2312^12
;;^UTILITY(U,$J,358.3,46480,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46480,1,3,0)
;;=3^Family Hx Other Eye Disorder
;;^UTILITY(U,$J,358.3,46480,1,4,0)
;;=4^Z83.518
;;^UTILITY(U,$J,358.3,46480,2)
;;=^5063383
;;^UTILITY(U,$J,358.3,46481,0)
;;=Z83.511^^176^2312^13
;;^UTILITY(U,$J,358.3,46481,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46481,1,3,0)
;;=3^Family Hx of Glaucoma
;;^UTILITY(U,$J,358.3,46481,1,4,0)
;;=4^Z83.511
;;^UTILITY(U,$J,358.3,46481,2)
;;=^5063382
;;^UTILITY(U,$J,358.3,46482,0)
;;=H35.3211^^176^2313^1
;;^UTILITY(U,$J,358.3,46482,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46482,1,3,0)
;;=3^Exudative AMD,RIGHT eye,active CNV
;;^UTILITY(U,$J,358.3,46482,1,4,0)
;;=4^H35.3211
;;^UTILITY(U,$J,358.3,46482,2)
;;=^5138521
;;^UTILITY(U,$J,358.3,46483,0)
;;=H35.3221^^176^2313^2
;;^UTILITY(U,$J,358.3,46483,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46483,1,3,0)
;;=3^Exudative AMD,LEFT eye,active CNV
;;^UTILITY(U,$J,358.3,46483,1,4,0)
;;=4^H35.3221
;;^UTILITY(U,$J,358.3,46483,2)
;;=^5138525
;;^UTILITY(U,$J,358.3,46484,0)
;;=H35.059^^176^2313^3
;;^UTILITY(U,$J,358.3,46484,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46484,1,3,0)
;;=3^Retinal CNV or NV,unspec
;;^UTILITY(U,$J,358.3,46484,1,4,0)
;;=4^H35.059
;;^UTILITY(U,$J,358.3,46484,2)
;;=^5005601
;;^UTILITY(U,$J,358.3,46485,0)
;;=H35.82^^176^2313^4
;;^UTILITY(U,$J,358.3,46485,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46485,1,3,0)
;;=3^Retinal Ischemia,unspec
;;^UTILITY(U,$J,358.3,46485,1,4,0)
;;=4^H35.82
;;^UTILITY(U,$J,358.3,46485,2)
;;=^5005716
;;^UTILITY(U,$J,358.3,46486,0)
;;=H35.81^^176^2313^5
;;^UTILITY(U,$J,358.3,46486,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46486,1,3,0)
;;=3^Retinal Edema,unspec
;;^UTILITY(U,$J,358.3,46486,1,4,0)
;;=4^H35.81
;;^UTILITY(U,$J,358.3,46486,2)
;;=^5005715
;;^UTILITY(U,$J,358.3,46487,0)
;;=E11.3211^^176^2313^6
;;^UTILITY(U,$J,358.3,46487,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46487,1,3,0)
;;=3^DM Type 2 Mild NPDR w/ CME,RIGHT eye
;;^UTILITY(U,$J,358.3,46487,1,4,0)
;;=4^E11.3211
;;^UTILITY(U,$J,358.3,46487,2)
;;=^5138331
;;^UTILITY(U,$J,358.3,46488,0)
;;=E11.3212^^176^2313^7
;;^UTILITY(U,$J,358.3,46488,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46488,1,3,0)
;;=3^DM Type 2 Mild NPDR w/ CME,LEFT eye
;;^UTILITY(U,$J,358.3,46488,1,4,0)
;;=4^E11.3212
;;^UTILITY(U,$J,358.3,46488,2)
;;=^5138332
;;^UTILITY(U,$J,358.3,46489,0)
;;=E11.3311^^176^2313^8
;;^UTILITY(U,$J,358.3,46489,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46489,1,3,0)
;;=3^DM Type 2 Mod NPDR w/ CME,RIGHT eye
;;^UTILITY(U,$J,358.3,46489,1,4,0)
;;=4^E11.3311
;;^UTILITY(U,$J,358.3,46489,2)
;;=^5138339
;;^UTILITY(U,$J,358.3,46490,0)
;;=E11.3312^^176^2313^9
;;^UTILITY(U,$J,358.3,46490,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,46490,1,3,0)
;;=3^DM Type 2 Mod NPDR w/ CME,LEFT eye
;;^UTILITY(U,$J,358.3,46490,1,4,0)
;;=4^E11.3312
;;^UTILITY(U,$J,358.3,46490,2)
;;=^5138340
;;^UTILITY(U,$J,358.3,46491,0)
;;=E11.3411^^176^2313^10
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2WZ 3748 printed Nov 22, 2024@17:47:36 Page 2
IBDEI2WZ ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,46479,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,46479,1,3,0)
+4 ;;=3^Family Hx Blindness/Visual Loss
+5 ;;^UTILITY(U,$J,358.3,46479,1,4,0)
+6 ;;=4^Z82.1
+7 ;;^UTILITY(U,$J,358.3,46479,2)
+8 ;;=^5063365
+9 ;;^UTILITY(U,$J,358.3,46480,0)
+10 ;;=Z83.518^^176^2312^12
+11 ;;^UTILITY(U,$J,358.3,46480,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,46480,1,3,0)
+14 ;;=3^Family Hx Other Eye Disorder
+15 ;;^UTILITY(U,$J,358.3,46480,1,4,0)
+16 ;;=4^Z83.518
+17 ;;^UTILITY(U,$J,358.3,46480,2)
+18 ;;=^5063383
+19 ;;^UTILITY(U,$J,358.3,46481,0)
+20 ;;=Z83.511^^176^2312^13
+21 ;;^UTILITY(U,$J,358.3,46481,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,46481,1,3,0)
+24 ;;=3^Family Hx of Glaucoma
+25 ;;^UTILITY(U,$J,358.3,46481,1,4,0)
+26 ;;=4^Z83.511
+27 ;;^UTILITY(U,$J,358.3,46481,2)
+28 ;;=^5063382
+29 ;;^UTILITY(U,$J,358.3,46482,0)
+30 ;;=H35.3211^^176^2313^1
+31 ;;^UTILITY(U,$J,358.3,46482,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,46482,1,3,0)
+34 ;;=3^Exudative AMD,RIGHT eye,active CNV
+35 ;;^UTILITY(U,$J,358.3,46482,1,4,0)
+36 ;;=4^H35.3211
+37 ;;^UTILITY(U,$J,358.3,46482,2)
+38 ;;=^5138521
+39 ;;^UTILITY(U,$J,358.3,46483,0)
+40 ;;=H35.3221^^176^2313^2
+41 ;;^UTILITY(U,$J,358.3,46483,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,46483,1,3,0)
+44 ;;=3^Exudative AMD,LEFT eye,active CNV
+45 ;;^UTILITY(U,$J,358.3,46483,1,4,0)
+46 ;;=4^H35.3221
+47 ;;^UTILITY(U,$J,358.3,46483,2)
+48 ;;=^5138525
+49 ;;^UTILITY(U,$J,358.3,46484,0)
+50 ;;=H35.059^^176^2313^3
+51 ;;^UTILITY(U,$J,358.3,46484,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,46484,1,3,0)
+54 ;;=3^Retinal CNV or NV,unspec
+55 ;;^UTILITY(U,$J,358.3,46484,1,4,0)
+56 ;;=4^H35.059
+57 ;;^UTILITY(U,$J,358.3,46484,2)
+58 ;;=^5005601
+59 ;;^UTILITY(U,$J,358.3,46485,0)
+60 ;;=H35.82^^176^2313^4
+61 ;;^UTILITY(U,$J,358.3,46485,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,46485,1,3,0)
+64 ;;=3^Retinal Ischemia,unspec
+65 ;;^UTILITY(U,$J,358.3,46485,1,4,0)
+66 ;;=4^H35.82
+67 ;;^UTILITY(U,$J,358.3,46485,2)
+68 ;;=^5005716
+69 ;;^UTILITY(U,$J,358.3,46486,0)
+70 ;;=H35.81^^176^2313^5
+71 ;;^UTILITY(U,$J,358.3,46486,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,46486,1,3,0)
+74 ;;=3^Retinal Edema,unspec
+75 ;;^UTILITY(U,$J,358.3,46486,1,4,0)
+76 ;;=4^H35.81
+77 ;;^UTILITY(U,$J,358.3,46486,2)
+78 ;;=^5005715
+79 ;;^UTILITY(U,$J,358.3,46487,0)
+80 ;;=E11.3211^^176^2313^6
+81 ;;^UTILITY(U,$J,358.3,46487,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,46487,1,3,0)
+84 ;;=3^DM Type 2 Mild NPDR w/ CME,RIGHT eye
+85 ;;^UTILITY(U,$J,358.3,46487,1,4,0)
+86 ;;=4^E11.3211
+87 ;;^UTILITY(U,$J,358.3,46487,2)
+88 ;;=^5138331
+89 ;;^UTILITY(U,$J,358.3,46488,0)
+90 ;;=E11.3212^^176^2313^7
+91 ;;^UTILITY(U,$J,358.3,46488,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,46488,1,3,0)
+94 ;;=3^DM Type 2 Mild NPDR w/ CME,LEFT eye
+95 ;;^UTILITY(U,$J,358.3,46488,1,4,0)
+96 ;;=4^E11.3212
+97 ;;^UTILITY(U,$J,358.3,46488,2)
+98 ;;=^5138332
+99 ;;^UTILITY(U,$J,358.3,46489,0)
+100 ;;=E11.3311^^176^2313^8
+101 ;;^UTILITY(U,$J,358.3,46489,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,46489,1,3,0)
+104 ;;=3^DM Type 2 Mod NPDR w/ CME,RIGHT eye
+105 ;;^UTILITY(U,$J,358.3,46489,1,4,0)
+106 ;;=4^E11.3311
+107 ;;^UTILITY(U,$J,358.3,46489,2)
+108 ;;=^5138339
+109 ;;^UTILITY(U,$J,358.3,46490,0)
+110 ;;=E11.3312^^176^2313^9
+111 ;;^UTILITY(U,$J,358.3,46490,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,46490,1,3,0)
+114 ;;=3^DM Type 2 Mod NPDR w/ CME,LEFT eye
+115 ;;^UTILITY(U,$J,358.3,46490,1,4,0)
+116 ;;=4^E11.3312
+117 ;;^UTILITY(U,$J,358.3,46490,2)
+118 ;;=^5138340
+119 ;;^UTILITY(U,$J,358.3,46491,0)
+120 ;;=E11.3411^^176^2313^10
